Stockreport

Clarus Therapeutics jumps over 50% after securing new U.S. patents for Jatenzo [Seeking Alpha]

Clarus Therapeutics Holdings, Inc.  (CRXT) 
PDF Clarus Therapeutics jumps over 50% after securing new U.S. patents for Jatenzo [Read more]